{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:42:28Z","timestamp":1762652548972,"version":"build-2065373602"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lunds Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009780","name":"Region Sk\u00e5ne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.josat.2023.209036","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T20:27:52Z","timestamp":1681244872000},"page":"209036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Malm\u00f6 Treatment Referral and Intervention Study (MATRIS)\u201436-month follow-up on retention and substance use among patients referred from needle exchange to opioid agonist treatment\u2014The role of stimulant use at baseline"],"prefix":"10.1016","volume":"151","author":[{"given":"Katja","family":"Troberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Br\u00e5b\u00e4ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernilla","family":"Isendahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzan","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Disa","family":"Dahlman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.josat.2023.209036_bb0005","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1080\/10826084.2017.1413114","article-title":"Perceived self-control is related to mental distress in patients entering substance use disorder treatment","volume":"53","author":"Abel","year":"2018","journal-title":"Substance Use & Misuse"},{"year":"2016","series-title":"Blood borne viruses (HIV, HBV and HCV) among participants of a Swedish needle exchange program [compilation, Lund University]","author":"Alanko Blom\u00e9","key":"10.1016\/j.josat.2023.209036_bb0010"},{"issue":"4","key":"10.1016\/j.josat.2023.209036_bb0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research","volume":"28","author":"Amato","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.josat.2023.209036_bb0020","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1360-0443.2009.02538.x","article-title":"Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users","volume":"104","author":"Banta-Green","year":"2009","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2023.209036_bb0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: The foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.josat.2023.209036_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fpsyt.2017.00161","article-title":"Malm\u00f6 treatment referral and intervention study-high 12-month retention rates in patients referred from syringe exchange to methadone or buprenorphine\/naloxone treatment","volume":"8","author":"Br\u00e5b\u00e4ck","year":"2017","journal-title":"Frontiers in Psychiatry"},{"issue":"5","key":"10.1016\/j.josat.2023.209036_bb0035","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/add.13249","article-title":"Malm\u00f6 Treatment Referral and Intervention Study (MATRIS)\u2014Effective referral from syringe exchange to treatment for heroin dependence: A pilot randomized controlled trial","volume":"111","author":"Br\u00e5b\u00e4ck","year":"2016","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2023.209036_bb5000","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10550880802122620","article-title":"The impact of benzodiazepine use on methadone maintenance treatment outcomes","volume":"27","author":"Brands","year":"2008","journal-title":"J Addict Dis"},{"issue":"7","key":"10.1016\/j.josat.2023.209036_bb0040","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1360-0443.2005.01089.x","article-title":"Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain","volume":"100","author":"Brugal","year":"2005","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.josat.2023.209036_bb0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/10826089609045806","article-title":"Methadone maintenance and addicts\u2019 risk of fatal heroin overdose","volume":"31","author":"Caplehorn","year":"1996","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"10.1016\/j.josat.2023.209036_bb0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000321259","article-title":"Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients","volume":"17","author":"Carpentier","year":"2011","journal-title":"European Addiction Research"},{"issue":"1","key":"10.1016\/j.josat.2023.209036_bb0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1360-0443.1968.tb05251.x","article-title":"The use of methadone for narcotic blockade","volume":"63","author":"Dole","year":"1968","journal-title":"The British Journal of Addiction to Alcohol and Other Drugs"},{"issue":"3","key":"10.1016\/j.josat.2023.209036_bb0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.drugalcdep.2010.06.013","article-title":"Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: Findings of the German randomized controlled trial","volume":"112","author":"Eiroa-Orosa","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"year":"2017","series-title":"European drug report 2017: Trends and developments","author":"European Monitoring Centre for Drugs and Drug Addiction","key":"10.1016\/j.josat.2023.209036_bb0065"},{"author":"European Monitoring Centre for Drugs and Drug Addiction","key":"10.1016\/j.josat.2023.209036_bb0070"},{"year":"2019","series-title":"Drug-related deaths and mortality in Europe: Update from the EMCDDA expert network","author":"European Monitoring Centre for Drugs and Drug Addiction","key":"10.1016\/j.josat.2023.209036_bb0075"},{"year":"2019","series-title":"European drug report 2019: Trends and developments","author":"European Monitoring Centre for Drugs and Drug Addiction","key":"10.1016\/j.josat.2023.209036_bb0080"},{"author":"European Monitoring Centre for Drugs and Drug Addiction","key":"10.1016\/j.josat.2023.209036_bb0085"},{"author":"European Monitoring Centre for Drugs and Drug Addiction","key":"10.1016\/j.josat.2023.209036_bb0090"},{"key":"10.1016\/j.josat.2023.209036_bb0095","article-title":"EMCDDA-European joint publications no 3","volume":"2011","author":"European Monitoring Centre for Drugs and Drug Addiction and Europol","year":"2011","journal-title":"Amphetamine: A European Union perspective in the global context."},{"key":"10.1016\/j.josat.2023.209036_bb0100","series-title":"Substance Misuse Management in General Practice, London","article-title":"Guidance for the use and reduction of misuse of benzodiazepines and other hypnotics and anxiolytics in general practice","author":"Ford","year":"2014"},{"issue":"1","key":"10.1016\/j.josat.2023.209036_bb0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12954-017-0134-5","article-title":"The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in northern and rural Ontario","volume":"14","author":"Franklyn","year":"2017","journal-title":"Harm Reduction Journal"},{"issue":"5","key":"10.1016\/j.josat.2023.209036_bb0110","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1360-0443.1995.tb02209.x","article-title":"Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment","volume":"90","author":"Fugelstad","year":"1995","journal-title":"Addiction"},{"issue":"1\u20132","key":"10.1016\/j.josat.2023.209036_bb0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0376-8716(98)00175-6","article-title":"Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: A 1 year prospective study in an Israeli clinic","volume":"55","author":"Gelkopf","year":"1999","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.josat.2023.209036_bb0125","article-title":"Oral substitution treatment of injecting opioid users for prevention of HIV infection","author":"Gowing","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.josat.2023.209036_bb0130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0447.1990.tb03057.x","article-title":"Mortality in heroin addiction: Impact of methadone treatment","volume":"82","author":"Gr\u00f6nbladh","year":"1990","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.josat.2023.209036_bb0135","doi-asserted-by":"crossref","first-page":"31992","DOI":"10.3402\/qhw.v11.31992","article-title":"Stuck in limbo: Illicit drug users\u2019 experiences with opioid maintenance treatment and the relation to recovery","volume":"11","author":"Gr\u00f8nnestad","year":"2016","journal-title":"International Journal of Qualitative Studies on Health and Well-Being"},{"issue":"3","key":"10.1016\/j.josat.2023.209036_bb0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0376-8716(81)90096-X","article-title":"The Swedish methadone maintenance program: A controlled study","volume":"7","author":"Gunne","year":"1981","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209036_bb0145","doi-asserted-by":"crossref","first-page":"6487217","DOI":"10.1155\/2016\/6487217","article-title":"Correlates of nine-month retention following interim buprenorphine-naloxone treatment in opioid dependence: A pilot study","volume":"2016","author":"H\u00e5kansson","year":"2016","journal-title":"Journal of Addiction"},{"issue":"3","key":"10.1016\/j.josat.2023.209036_bb0150","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jsat.2008.07.002","article-title":"Predictors of opiate agonist treatment retention among injection drug users referred from a needle exchange program","volume":"36","author":"Havens","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2023.209036_bb0155","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/08897077.2019.1635557","article-title":"Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: Lessons learned from Seattle, Washington","volume":"41","author":"Hood","year":"2020","journal-title":"Substance Abuse"},{"issue":"5","key":"10.1016\/j.josat.2023.209036_bb0160","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","article-title":"A 33-year follow-up of narcotics addicts","volume":"58","author":"Hser","year":"2001","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1016\/j.josat.2023.209036_bb0165","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1176\/ajp.2007.164.5.797","article-title":"A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: A randomized controlled trial","volume":"164","author":"Kakko","year":"2007","journal-title":"The American Journal of Psychiatry"},{"issue":"9358","key":"10.1016\/j.josat.2023.209036_bb0170","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomised, placebo-controlled trial","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.josat.2023.209036_bb0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1300\/J069v25n03_03","article-title":"Adolescent and young adult heroin patients: Drug use and success in methadone maintenance treatment","volume":"25","author":"Kellogg","year":"2006","journal-title":"Journal of Addictive Diseases"},{"issue":"2\u20133","key":"10.1016\/j.josat.2023.209036_bb0180","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2011.01.008","article-title":"Predictors of methadone treatment retention from a multi-site study: A survival analysis","volume":"117","author":"Kelly","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209036_bb0185","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.drugalcdep.2018.03.009","article-title":"Treatment initiation strategies for syringe exchange referrals to methadone maintenance: A randomized clinical trial","volume":"187","author":"Kidorf","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.josat.2023.209036_bb0190","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/070674370805300803","article-title":"Expanding the public health benefits of syringe exchange programs","volume":"53","author":"Kidorf","year":"2008","journal-title":"Canadian Journal of Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.josat.2023.209036_bb0195","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drugalcdep.2011.12.008","article-title":"Improving treatment enrollment and re-enrollment rates of syringe exchangers: 12-month outcomes","volume":"124","author":"Kidorf","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2023.209036_bb0200","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","article-title":"Benzodiazepine harm: How can it be reduced?","volume":"77","author":"Lader","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.josat.2023.209036_bb0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2015.01.009","article-title":"Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment","volume":"54","author":"Levine","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209036_bb0210","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis","volume":"345","author":"MacArthur","year":"2012","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.josat.2023.209036_bb0215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","article-title":"Interventions to prevent HIV and hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness","volume":"25","author":"MacArthur","year":"2014","journal-title":"The International Journal on Drug Policy"},{"issue":"3","key":"10.1016\/j.josat.2023.209036_bb0220","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2009","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.josat.2023.209036_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"13","key":"10.1016\/j.josat.2023.209036_bb0230","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.josat.2023.209036_bb0235","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugalcdep.2008.03.026","article-title":"A comparison of 1-year substance abuse treatment outcomes in community syringe exchange participants versus other referrals","volume":"97","author":"Neufeld","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"8141","key":"10.1016\/j.josat.2023.209036_bb0240","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(79)91550-2","article-title":"Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong","volume":"2","author":"Newman","year":"1979","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.josat.2023.209036_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232086","article-title":"Retention of patients in opioid substitution treatment: A systematic review","volume":"15","author":"O\u2019Connor","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.josat.2023.209036_bb0250","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jval.2020.12.023","article-title":"Economic evaluations of pharmacologic treatment for opioid use disorder: A systematic literature review","volume":"24","author":"Onuoha","year":"2021","journal-title":"Value in Health"},{"issue":"4","key":"10.1016\/j.josat.2023.209036_bb0255","first-page":"285","article-title":"Benzodiazepine usage during 19.5 years in methadone maintenance treatment patients and its relation to long-term outcome","volume":"51","author":"Peles","year":"2014","journal-title":"The Israel Journal of Psychiatry and Related Sciences"},{"issue":"4","key":"10.1016\/j.josat.2023.209036_bb0260","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10550880802324382","article-title":"One-year and cumulative retention as predictors of success in methadone maintenance treatment: A comparison of two clinics in the United States and Israel","volume":"27","author":"Peles","year":"2008","journal-title":"Journal of Addictive Diseases"},{"issue":"3","key":"10.1016\/j.josat.2023.209036_bb0265","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.drugalcdep.2005.09.004","article-title":"Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel","volume":"82","author":"Peles","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"2\u20133","key":"10.1016\/j.josat.2023.209036_bb0270","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2009.09.013","article-title":"15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel","volume":"107","author":"Peles","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209036_bb0275","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2017.11.034","article-title":"Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center","volume":"185","author":"Peles","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"10.1016\/j.josat.2023.209036_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012021.pub2","article-title":"Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs","author":"Platt","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.josat.2023.209036_bb0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jsat.2004.03.001","article-title":"A longitudinal evaluation of treatment engagement and recovery stages","volume":"27","author":"Simpson","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2023.209036_bb0290","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1037\/0893-164X.11.4.279","article-title":"Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS)","volume":"11","author":"Simpson","year":"1997","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1016\/j.josat.2023.209036_bb0295","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"year":"200927","series-title":"[The National Board of Health and Welfare]. Socialstyrelsens f\u00f6reskrifter och allm\u00e4nna r\u00e5d om l\u00e4kemedelsassisterad behandling vid opiatberoende [Code of statutes (SOSFS 2009:27) regulating opiate substitution treatment]","author":"SOSFS","key":"10.1016\/j.josat.2023.209036_bb0300"},{"author":"SOU","key":"10.1016\/j.josat.2023.209036_bb0305"},{"year":"2020","series-title":"IBM SPSS statistics for windows, version 27.0","author":"SPSS version 27.0. IBM Corp. Released","key":"10.1016\/j.josat.2023.209036_bb0310"},{"issue":"6","key":"10.1016\/j.josat.2023.209036_bb0315","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/add.12860","article-title":"Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian Treatment Outcome Study","volume":"110","author":"Teesson","year":"2015","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2023.209036_bb0320","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1360-0443.2007.02029.x","article-title":"The impact of treatment on 3 years\u2019 outcome for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS)","volume":"103","author":"Teesson","year":"2008","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2023.209036_bb0325","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.drugalcdep.2005.11.020","article-title":"Predictors of retention in methadone programs: A signal detection analysis","volume":"83","author":"Villafranca","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"9148","key":"10.1016\/j.josat.2023.209036_bb0330","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","article-title":"Role of maintenance treatment in opioid dependence","volume":"353","author":"Ward","year":"1999","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.josat.2023.209036_bb0335","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2023.209036_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108996","article-title":"Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone","volume":"228","author":"Zhu","year":"2021","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923000863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923000863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:40:22Z","timestamp":1762652422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923000863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":68,"alternative-id":["S2949875923000863"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209036","relation":{},"ISSN":["2949-8759"],"issn-type":[{"type":"print","value":"2949-8759"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malm\u00f6 Treatment Referral and Intervention Study (MATRIS)\u201436-month follow-up on retention and substance use among patients referred from needle exchange to opioid agonist treatment\u2014The role of stimulant use at baseline","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209036"}}